The immune mechanisms responsible for development of Lyme arthritis are partially understood with interleukin-17 (IL-17) and gamma-interferon (IFN-γ ) playing a generally accepted role. Elevated levels of IL-17 and/or IFN-γ have been reported in samples from human Lyme arthritis patients and experimental mice. In addition, IL-17 and IFN-γ have been implicated in the onset of arthritis in Borrelia-primed and -infected C57BL/6 mice. Recently, we showed that IL-17-deficient mice developed swelling and histopathological changes consistent with arthritis in the presence of high levels of IFN-γ . We hypothesized that neutralization of IFN-γ in IL-17-deficient mice would inhibit Borrelia-induced arthritis. Our results, however, showed that swelling of the hind paws and histopathological changes of arthritis did not differ between Borrelia-primed and -infected IL-17-deficient and wild-type mice with or without neutralization of IFN-γ . We also found higher levels of tumor necrosis factor alpha (TNF-α) and IL-6 in the popliteal lymph node cells of Borrelia-primed and -infected IL-17-deficient mice after neutralization of IFN-γ . These results suggest that multiple cytokines interact in the development of Borrelia-induced arthritis.
INTRODUCTION
We recently showed that Borrelia-induced arthritis occurred in mice deficient of interleukin-17 (IL-17) (Kuo et al. 2016) . More specifically, IL-17-deficient C57BL/6 mice primed with heatinactivated Borrelia and then infected with a viable heterologous borrelial strain developed severe swelling of the hind paws. In contrast, IL-17-deficient and wild-type mice that were solely primed or infected had minimal or no changes in swelling of the hind paws (Kuo et al. 2016) . Borrelia-primed and -infected IL-17-deficient and wild-type mice also exhibited moderate to severe infiltration of lymphocytes, mild infiltration of polymorphonuclear cells, and some degree of hyperplasia and villus formation (Kuo et al. 2016) . Although IL-17 has been shown to contribute to the induction of arthritis upon exposure to borrelial spirochetes in humans (Infante-Duarte et al. 2000; Codolo et al. 2008 Codolo et al. , 2013 D'Elios, Codolo and de Bernard 2009; Henningsson et al. 2011 ) and in mice (Burchill et al. 2003; Nardelli et al. 2004 Nardelli et al. , 2008 Knauer et al. 2007; Kotloski et al. 2008; Kuo et al. 2011; Oosting et al. 2011; Hansen et al. 2013 Hansen et al. , 2016 , the arthritis reported in IL-17-deficient mice, when compared to their wild-type counterparts, suggests that IL-17 is not absolutely required for the development of arthritis. Moreover, elevated gamma-interferon (IFN-γ ) levels were detected in sera along with increased frequency of IFN-γ -expressing lymphocytes in the popliteal lymph nodes draining the arthritic site of Borrelia-primed and -infected IL-17-deficient mice compared to Borrelia-primed and -infected wild-type mice (Kuo et al. 2016) . This suggests that development of Borrelia-induced arthritis in the absence of IL-17 may be attributed to IFN-γ .
IFN-γ has been implicated in the development of later-stage Lyme arthritis (Yssel et al. 1991; Dong, Edelstein and Glickstein 1997; Yin et al. 1997; Gross, Steere and Huber 1998; Strle et al. 2012) , with T cells contributing to arthritic progression (Chen et al. 1999; Pianta et al. 2015) . More specifically, synovial fluid of human patients with Lyme arthritis, even after treatment with antibiotics, contained exceptionally high levels of IFN-γ (Shin, Glickstein and Steere 2007) , which may be due to the presence of CD4 + Th1 (Yssel et al. 1991; Gross, Steere and Huber 1998) and CD8 + cytotoxic T cells (Dong, Edelstein and Glickstein 1997 ).
An increase in IFN-γ levels was also observed after stimulating peripheral blood mononuclear cells (Strle et al. 2012) or synovial fluid mononuclear cells (Yin et al. 1997) from Lyme arthritis patients with borrelial spirochetes. In contrast, Borrelia-primed IFN-γ -deficient mice develop severe arthritis after infection with Borrelia burgdorferi (Burchill et al. 2003; Christopherson et al. 2003; Nardelli et al. 2004; Amlong et al. 2006 ) and the arthritis was dependent on IL-17. In mice with proteoglycan-induced arthritis, overproduction of IFN-γ compensated for the absence of IL-17 (Doodes et al. 2008 ) and vice versa (Doodes et al. 2010 ). Therefore, shifting production to IL-17 or IFN-γ in these respective animal models of cytokine deficiency could account for the development of arthritis. In this study, we hypothesized that neutralization of IFN-γ with anti-IFN-γ antibody would inhibit development of arthritis in Borrelia-infected IL-17-deficient C57BL/6 mice. However, we provide evidence that swelling and histopathological changes consistent with arthritis developed in Borrelia-primed andinfected IL-17-deficient C57BL/6 mice treated with anti-IFN-γ antibody. Our results indicate that both IL-17 and IFN-γ are not absolutely necessary for, but contribute to, the induction of arthritis.
MATERIALS AND METHODS

Mice
Six-to eight-week-old male IL-17-deficient C57BL/6 mice were provided by Dr Bruce Klein and Dr Marcel Wuethrich (University of Wisconsin School of Medicine and Public Health) with permission from Dr Yoichiro Iwakura (University of Tokyo's Institute of Medical Science). Wild-type mice of the same age were purchased from Jackson Laboratory (West Sacramento, CA). All mice were kept at the animal facility located at the University of Wisconsin School of Medicine and Public Health. Mice were maintained under a pathogen-free condition at 21
• C with food and acidified water provided ad libitum during daily cycles of twelve hours of light and darkness. Experimental protocols were approved by the Animal Care and Use Committee of the University of Wisconsin School of Medicine and Public Health.
Organisms and preparation
Low-passage-number (<10) virulent Borrelia bissettii (formerly known as B. burgdorferi strain C-1-11, isolated from Microtus pennsylvanicus) and B. burgdorferi isolate 297 (isolated from human spinal fluid) were cultured in modified Barbour-StoennerKelly (BSK) medium until reaching a concentration of 10 7 spirochetes ml −1 . Samples of 500 μl were dispensed into 1.5 ml screw cap tubes (Sarstedt; Newton, NC) containing 500 μl of BSK medium with 10% glycerol (Sigma-Aldrich; St. Louis, MO). Spirochetes were stored at −70 • C until used.
Priming of mice
A frozen suspension of B. bissettii was thawed, heated in a water bath at 56
• C for 30 min, and examined by darkfield microscopy for no motility. Heat-inactivated B. bissettii organisms were then washed three times by centrifugation at 10 000 × g with ice-cold phosphate-buffered saline (PBS, pH 7.4) that was filter-sterilized with a 0.2-μm-pore-size filter (Gelman Sciences; Ann Arbor, MI). Subsequently, washed B. bissettii organisms were resuspended in PBS and mixed with a volume of 1% aluminum hydroxide (Reheis; Berkeley Heights, NJ) to yield a concentration of 2 × 10 6 spirochetes ml −1 . Mice were then anesthetized with isoflurane using a nose-and-mouth cup and injected subcutaneously in the sural region near the popliteal lymph node of the hind limb with 0.10 ml of the vaccine using a 23-gauge needle.
Infection of mice
A frozen suspension of B. burgdorferi isolate 297 was thawed and mixed with 4 ml of fresh BSK medium. The spirochetal culture was incubated at 32
• C until reaching a concentration of 2 × 10 7 viable spirochetes ml −1 . Twenty-one days after priming of mice with heat-inactivated B. bissettii, mice were anesthetized with isoflurane using a nose-and-mouth cup and injected subcutaneously in the right hind paw with 1 × 10 6 (50 μl) B. burgdorferi isolate 297 organisms with a 27-gauge needle. The heterologous infection with B. burgdorferi isolate 297 induces arthritis and is not affected by the presence of anti-B. bissettii antibodies induced after priming with B. bissettii. Infection with viable, but not non-viable, heterologous Borrelia organisms can induce arthritis (Lim et al. 1995) . If priming and infection are conducted with the same isolate of B. burgdorferi, arthritis will not develop if specific borreliacidal antibodies are present (Croke et al. 2000) . Controls also included mice injected with BSK medium.
Administration of IFN-γ antibody
Mice were injected with 1 μg (in 0.1 ml filter-sterilized PBS, pH 7.4) polyclonal goat anti-mouse IFN-γ antibody (R&S Systems; Minneapolis, MN) or immunoglobulin G isotype control antibody in the right hind paw 1 h after infection and daily thereafter for 5 days.
Assessment of swelling
Swelling of the right hind paws of mice was measured with a digital caliper (Mitutoyo American Corporation, Aurora, IL) with a sensitivity of 0.01 mm prior to infection with B. burgdorferi isolate 297 and every other day for 8 days. Caliper values within a group were averaged to obtain the mean caliper value for comparison of the degree of swelling.
Histological examination
Mice were euthanized with isoflurane 8 days after infection, and the right hind paw of each mouse was amputated at mid femur. Paws were first placed in decalcifying solution (Lerner Laboratories, Pittsburgh, PA) for 24 h, and then stored in 10% neutral buffered formalin solution for 48 h (Sigma-Aldrich, St. Louis, MO). Paws were then placed in tissue-embedding cassettes (Fisher Scientific, Hanover Park, IL), embedded in paraffin and cut into three to five 6-μm-thick sections. Each section of the hind paws was placed onto a glass slide and stained with hematoxylin and eosin. Sections were cryptically coded, and a board-certified pathologist (TFW) performed fully blinded histopathological examinations of the tissues. The following ratings were used: 0, no histopathological changes; 1, mild infiltration of polymorphonuclear cells; 2, hyperplasia or villus formation with moderate infiltration of polymorphonuclear cells and lymphocytes; 3, severe hyperplasia with villus formation and infiltration of polymorphonuclear cells and lymphocytes.
Flow cytometry
Popliteal lymph nodes of mice were obtained 8 days after infection. Single-cell suspensions of lymph node cells were prepared by passing cells through a sterile nylon mesh screen (Fisher) into cold filter-sterilized PBS in centrifuge tubes on ice. Total numbers of viable cells were determined using trypan blue exclusion and enumeration with a hemocytometer. The suspensions were diluted to 1 × 10 7 cells ml −1 . A total of 5 × 10 5 cells from each sample were then transferred to a sterile tissue culture treated 96-well plate (Corning, Corning, NY). Cells were incubated in the dark at 4
• C for 30 min during surface staining with fluorescein isothiocyanate-conjugated rat anti-mouse CD4 antibody (BD Biosciences, San Jose, CA). The antibody-to-cell ratio was determined to maximize recognition of CD4 + cells. Isotype controls were also included. After incubation, cells were permeabilized, and stained intracellularly with allophycocyanin-conjugated rat anti-mouse IFN-γ antibody, phycoerythrin-cyanine 7-conjugated rat anti-mouse TNF-α antibody and BD Horizon V450-conjugated rat anti-mouse IL-6 antibody (BD Biosciences) in the dark at 4
• C for 30 min. Cells were then fixed with 5% formalin, and data were acquired using a BD LSRFortessa cell analyzer (BD Biosciences). Events were gated to include viable lymphocytes that were CD4 + and evaluated for expressing IFN-γ , TNF-α or IL-6. The percentage of these specific cells was determined from the entire lymphoid organ population. A total of 30 000 gated events were collected and analyzed with FlowJo single cell analysis software (Tree Star, Ashland, OR).
Statistics
Swelling of the hind paws among different groups of Borreliaprimed and -infected mice and percentage of cytokineproducing cells were evaluated by Fisher's protected leastsignificant-difference test and one-way analysis of variance through R Commander. The alpha level was set at 0.05. Data are presented as the average with two standard errors of the mean.
RESULTS
Hind paw swelling in IL-17-deficient C57BL/6 mice after treatment with anti-IFN-γ antibody
The objective of this study was to determine if Borrelia-primed and -infected IL-17-deficient mice developed hind paw swelling after neutralization of IFN-γ . Wild-type and IL-17-deficient mice were randomly assigned into the following groups: non-primed and uninfected, Borrelia-primed but uninfected, non-primed but Borrelia-infected, and Borrelia-primed and -infected. Mice in each group were then divided into those administered anti-IFN-γ antibody or an isotype control antibody. Each treatment group had four mice, and the study was replicated twice.
No swelling of the hind paws was detected in IL-17-deficient (Fig. 1A) or wild-type (Fig. 1B) C57BL/6 mice that were only infected with Borrelia burgdorferi or solely primed with B. bissettii with or without anti-IFN-γ antibody. By contrast, significant swelling (P < 0.05) of the hind paws was detected in Borreliaprimed and -infected IL-17-deficient and wild-type mice with or without treatment with anti-IFN-γ antibody from days 2 to 8 of infection. In addition, no significant differences in hind paw swelling were detected between Borrelia-primed and -infected IL-17-deficient and wild-type mice treated with or without anti-IFN-γ antibody. Moreover, no swelling of the hind paws was detected with non-primed and uninfected mice treated with or without anti-IFN-γ antibody. Similar results were obtained when this study was repeated twice.
Histopathological confirmation of arthritis
Hyperplasia was observed in the synovium of non-primed but Borrelia-infected IL-17-deficient mice administered isotype control antibody (Table 1) . Hyperplasia was also detected in Borreliaprimed and -infected IL-17-deficient and wild-type mice treated with or without anti-IFN-γ antibody. Infiltration of macrophages was decreased in the tibiotarsal joints of non-primed but Borrelia-infected IL-17-deficient and wild-type mice compared to Borrelia-primed and -infected IL-17-deficient and wild-type mice. However, macrophage infiltration was limited in Borreliaprimed and -infected IL-17-deficient and wild-type mice administered anti-IFN-γ antibody. Moreover, Borrelia-primed and -infected IL-17-deficient and wild-type mice administered anti-IFN-γ antibody had more pronounced infiltration of polymorphonuclear cells in the perisynovium than the other groups, except for non-primed but Borrelia-infected IL-17-deficient and wild-type mice administered anti-IFN-γ antibody. Pronounced lymphocytic infiltration was also noted in Borrelia-primed and -infected IL-17-deficient and wild-type mice with or without anti-IFN-γ antibody compared to the other groups. However, no significant difference was detected in lymphocytic infiltration between Borrelia-primed and -infected IL-17-deficient and wild-type mice treated with or without anti-IFN-γ antibody. No histopathological changes were detected in non-primed and uninfected and Borrelia-primed but uninfected mice treated with or without anti-IFN-γ antibody.
IFN-γ , TNF-α and IL-6 in popliteal lymph node cells
CD4
+ popliteal lymph node cells were obtained from nonprimed and uninfected, Borrelia-primed but uninfected, nonprimed but Borrelia-infected, and Borrelia-primed and -infected mice with and without treatment with anti-IFN-γ antibody. Development of hind paw swelling of IL-17-deficient (A) and wild-type (B) C57BL/6 mice that were non-primed and uninfected, Borrelia primed but uninfected, non-primed but Borrelia infected, and Borrelia primed and infected with or without treatment with anti-IFN-γ antibody. Wild-type mice did not demonstrate significant differences in swelling of the hind paws compared to IL-17-deficient counterparts with or without treatment with anti-IFN-γ antibody. Error bars represent the mean hind paw swelling ± two standard errors. Asterisks denote a significant (P ≤ 0.05) difference in swelling among groups of mice. Data were obtained from three experiments. Twelve mice were used in total per group.
Popliteal lymph node cells were examined for expression of IFN-γ , TNF-α and IL-6 using flow cytometry. The percentage of CD4 + popliteal lymph node cells expressing IFN-γ was significantly higher in Borrelia-primed and -infected IL-17-deficient mice that did not receive anti-IFN-γ antibody compared to the other groups of mice ( Fig. 2A) . In contrast, cells derived from Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody expressed comparable levels of IFN-γ to all other groups of mice.
A significant percentage of CD4 + lymphocytes obtained from popliteal lymph node cells of Borrelia-primed and -infected, and non-primed but Borrelia-infected, IL-17-deficient and wild-type mice with or without treatment with anti-IFN-γ antibody expressed detectable levels of TNF-α compared to primed but uninfected, and non-primed and uninfected mice (Fig. 2B) . However, significantly greater expression of TNF-α occurred with cells from Borrelia-primed and -infected IL-17-deficient and wild-type mice than from non-primed but Borrelia-infected IL-17-deficient and wild-type mice. Moreover, Borrelia-primed and -infected IL-17-deficient and wild-type mice administered anti-IFN-γ antibody had greater expression of TNF-α in the popliteal lymph node cells compared to Borrelia-primed and -infected IL-17-deficient and wild-type mice administered isotype control antibody. Furthermore, Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody also had significantly higher levels of TNF-α-expressing CD4 + lymphocytes compared to the wild-type counterparts.
The percentage of IL-6-expressing CD4 + popliteal lymph node cells obtained from Borrelia-primed and -infected IL-17-deficient and wild-type mice with or without treatment with anti-IFN-γ antibody was significantly greater than percentages of IL-6-expressing CD4+ cells obtained from non-primed and uninfected, Borrelia-primed but uninfected, and non-primed but Borrelia-infected IL-17-deficient and wild-type mice (Fig. 2C) . However, significantly greater IL-6 expression was detected in Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody than Borrelia-primed and -infected IL-17-deficient mice administered isotype control antibody. Furthermore, significantly higher IL-6 expression was observed in Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody compared to Borrelia-primed and -infected wild-type mice with or without treatment with anti-IFN-γ antibody. IL-6 expression in the popliteal lymph node cells was comparable between Borrelia-primed and -infected wild-type mice treated with or without anti-IFN-γ antibody.
DISCUSSION
The induction of Lyme arthritis has been attributed to secretion of various cytokines from innate antigen-presenting cells and other cells during the onset of acquired immunity (Chen et al. 1999; Pianta et al. 2015) . Several lines of evidence have shown that the cytokine IL-17, mainly produced by Th17 lymphocytes, is involved. Oosting et al. (2011) reported elevated levels of IL-17 by host immune cells against Borrelia in mice. Human and murine T cells were also observed by Infante-Duarte et al. (2000) to produce IL-17 upon interaction with borrelial outer surface A protein. Another report showed that Borrelia burgdorferistimulated murine bone marrow-derived dendritic cells produced IL-17 and other Th17-induced cytokines (Knauer et al. 2007) . Moreover, neutrophil activating protein A of B. burgdorferi stimulated the release of IL-17 from synovial T cells of human Lyme arthritis patients (Codolo et al. 2008 (Codolo et al. , 2013 . Taken together, these results suggest that IL-17 is an important cytokine associated with Lyme arthritis. Recently, we also showed that IL-17 plays an important role in the induction of Lyme arthritis (Burchill et al. 2003; Christopherson et al. 2003; Nardelli et al. 2004 Nardelli et al. , 2005 Nardelli et al. , 2006 Nardelli et al. , 2008 Amlong et al. 2006; Kotloski et al. 2008; Kuo et al. 2011; Hansen et al. 2013) . When Borrelia-primed mice were infected with B. burgdorferi, they developed arthritis. However, treatment of Borrelia-primed and -infected mice with anti-IL-17 antibody inhibited the development of arthritis. This suggested that IL-17 was a major player in the induction of Lyme arthritis. However, Kuo et al. (2016) also showed that arthritis developed in Borrelia-infected IL-17-deficient C57BL/6 mice upon priming of immune cells. Lasky et al. (2015) also observed no effect on the development of Borrelia-induced arthritis between genetically susceptible wildtype C3H mice and those devoid of IL-17 receptor A (IL-17RA). We, therefore, speculated that the arthritis observed in these IL-17-deficient mice could be attributed to elevated IFN-γ levels. In support, we showed that Borrelia-primed and -infected IL-17-deficient mice had substantial levels of IFN-γ in their sera and popliteal lymph node cells (Kuo et al. 2016) .
IFN-γ is another key cytokine that has been shown to drive inflammation upon borrelial infection (Yssel et al. 1991; Yin et al. 1997; Gross, Steere and Huber 1998; Strle et al. 2012) . It is produced by human synovial fluid mononuclear cells from Lyme arthritic patients (Yin et al. 1997) and peripheral blood mononuclear cells from patients with antibiotic-refractory Lyme arthritis (Strle et al. 2012) . Moreover, IFN-γ was detected in synovial fluids of human Lyme arthritis patients and was produced by Th1 lymphocytes (Yssel et al. 1991; Yin et al. 1997; Gross, Steere and Huber 1998; Strle et al. 2012) . By contrast, IFN-γ -deficient C3H mice (Brown and Reiner 1999) and Borrelia-primed IFN-γ -deficient C57BL/6 mice (Burchill et al. 2003; Christopherson et al. 2003; Nardelli et al. 2004; Amlong et al. 2006) developed severe arthritis upon infection with Borrelia. This suggested that IFN-γ is not required for Borrelia-induced arthritis.
It is possible that both IL-17 and IFN-γ are involved in the induction of Lyme arthritis. When Borrelia-primed and -infected IFN-γ -deficient C57BL/6 mice were administered anti-IL-17 antibody, arthritis was inhibited (Burchill et al. 2003) . This suggested that the observed arthritis was driven by IL-17 (Burchill et al. 2003) . However, Borrelia-primed and -infected IL-17-deficient mice also developed arthritis (Kuo et al. 2016) . Since these mice had high level of IFN-γ , IFN-γ may be responsible for the induction of arthritis. We speculated that a shift in cytokine production between IL-17 and IFN-γ could account for the development of arthritis in both animal models of Lyme arthritis. There is evidence that compensatory cytokine mechanisms do exist (Doodes et al. 2008 (Doodes et al. , 2010 . Therefore, we hypothesized that treatment of Borrelia-primed and -infected IL-17-deficient mice with anti-IFN-γ antibody would inhibit the development of arthritis. However, contrary to our hypothesis, arthritis developed in Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody. Borrelia-primed and -infected IL-17-deficient and wild type-mice treated with anti-IFN-γ antibody developed swelling of the hind paws and histopathological changes consistent with arthritis. Borrelia-primed and -infected IL-17-deficient and wild-type C57BL/6 mice administered anti-IFN-γ antibody developed comparable hind paw swelling and similar degree of hyperplasia with lymphocytic infiltrations in the synovium. In addition, production of IFN-γ was greatly inhibited in Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody. Therefore, production of other inflammatory cytokines may be involved in the development of Borrelia-induced arthritis.
Our results also show that high levels of TNF-α and IL-6 are detected in Borrelia-primed and -infected IL-17-deficient and wild-type C57BL/6 mice with or without administration of anti-IFN-γ antibody. Could these cytokines be responsible for the induction of Lyme arthritis in the absence of IL-17 and neutralization of IFN-γ ? TNF-α is produced primarily by macrophages, neutrophils and CD4 + lymphocytes. Yin et al. (1997) reported increased levels after exposing immune cells from human Lyme disease patients to Borrelia in vitro. Similarly, IL-6 has been shown to be secreted by T cells and monocytes from human Lyme disease patients (Codolo et al. 2008) . Most importantly, when examining synovial fluids of human Lyme arthritis patients, Shin, Glickstein and Steere (2007) noted high levels of TNF-α, IL-6 and IFN-γ compared to other cytokines. In support of an active role for cytokines in Lyme arthritis, Christopherson et al. (2003) showed that arthritis was enhanced in Borrelia-primed andinfected IFN-γ -deficient C57BL/6 mice administered anti-TNF-α antibody. Nardelli et al. (2008) observed severe osteoarthropathy, lymphocytic infiltrations and destruction of articular cartilage in Borrelia-primed and -infected wild-type C57BL/6 mice administered anti-IL-6 antibody. In this study, we showed CD4 + popliteal lymph node cells expressing TNF-α and IL-6 in Borrelia-primed and -infected IL-17-deficient and wild-type mice with or without anti-IFN-γ antibody. Significantly higher percentages of TNF-α and IL-6-expressing CD4 + popliteal lymph node cells were detected in Borrelia-primed and -infected IL-17-deficient and wildtype mice after treatment with anti-IFN-γ antibody compared to other experimental groups. These results indicate that other cytokines, such as TNF-α and IL-6, may contribute to Borreliainduced arthritis in mice with low to no expressions of IL-17 and IFN-γ . In summary, we show that Borrelia-primed and -infected IL-17-deficient mice administered anti-IFN-γ antibody developed arthritis. In addition, these mice produced elevated levels of TNF-α and IL-6. These results suggest that cytokine interactions contribute to the development of Lyme arthritis. Future studies include investigating the interactions among proinflammatory cytokines as potential therapeutic targets to treat and alleviate Lyme arthritis.
